Associate Director -
Sales and Marketing
Head of Portfolio strategy
and Region Head China
Director - Sales and Marketing
Associate VP and Head,
Global Customer Support
and Program Management
Vice President and Head -
Vertical Head -
API Product Management
Vice President and
Head Chemical Sourcing
Associate Director, Marketing
CPHI China is Asia's premier pharma event that brings together leading pharma experts from across the end-to-end pharma supply chain. The event offers a one-stop shop for the pharmaceutical industry, allowing attendees to access a vast array of pharmaceutical ingredients, machinery, laboratory equipment, environmental protection, pharma packaging, and processing solutions - all conveniently located under one roof.
With thousands of local and international exhibitors in attendance, this year's edition promises to be the best one yet. Attendees can source cutting-edge solutions, and attend a range of presentations, forums, showcases, and other industry events to expand their knowledge and expertise.
The event offers more flexibility and pre-connect opportunities to attendees who want to network with peers face-to-face to connect with potential business prospects and collaborate to overcome challenges. With a jam-packed conference planned across 3 days, attendees can learn from experts, leaders, and fresh new voices, staying ahead of all pharma trends.
Join us this June, where the show will return for the first time in three years, and be part of this exciting event that offers limitless possibilities for professionals looking to expand their business in China's booming pharma market!
We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 150+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.
Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.
Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.
本目錄中的任何信息（包括對任何產品或服務的任何引用）均不構成銷售要約，或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是，只要存在此類監管豁免，就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估，並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途，但可用於第 107A 節。